← All stories
Markets
Ananda Developments (LSE:ANA) Puts Clinical Evidence In Focus
Highlights Investor attention in medical cannabis increasingly depends on credible research pathways and the translation of development work into regulated products. Ananda Developments, Celadon Pharmaceuticals (LSE:CEL) and Kanabo Group (L…
Covered by 1 outlet
All coverage · 1 article